Corporate Disclosure2022
-
Dec. 27, 2022
(Change of Disclosure Matters) Notice Concerning Transfer of Shares of Specified Subsidiary Engaged in Scientific Solutions Business
-
Dec. 20, 2022
Notice Regarding Acquisition of Odin Medical Ltd. (to make it a subsidiary) in the UK
-
Dec. 16, 2022
Notice Regarding Termination of Sponsored American Depositary Receipt (ADR) Program
-
Dec. 09, 2022
Notice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System
-
Dec. 02, 2022
Notice Regarding Status of Share Repurchase
-
Nov. 21, 2022
(Updated) Consolidated Financial Results for the Six Months of the Fiscal Year Ending March 31, 2023
-
Nov. 21, 2022
(Updated) Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System
-
Nov. 11, 2022
Notice Concerning Recording Gain on Transfer of Shares and Revision to Financial Forecasts
-
Nov. 11, 2022
Notice Regarding Share Repurchase and Cancellation of Treasury Shares
-
Nov. 11, 2022
Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation System
-
Oct. 21, 2022
Notice Concerning Changes of Representative Executive Officer and Management Team
-
Aug. 29, 2022
Notice Concerning Transfer of Shares of Specified Subsidiary engaged in Scientific Solutions Business
-
Aug. 23, 2022
Company Response to Today’s Media Reports
-
Jul. 22, 2022
Notice of Completion of Payment for Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
-
Jun. 24, 2022
Notice of Disposal of Treasury Shares based on Subsequent Grant-type Restricted Stock Unit Compensation and Performance-linked Stock Compensation Systems
-
Jun. 17, 2022
Overview of Evaluation Results on the Effectiveness of the Board of Directors of Olympus
-
May. 11, 2022
Notice Regarding Cancellation of Treasury Shares
-
Apr. 06, 2022
Notice Concerning Capital Increase in Subsidiary (Change to Specified Subsidiary)
-
Apr. 01, 2022
(Progress of Disclosure Matters) Notice Concerning Complete of Reorganization of Scientific Solutions Business through Company Split (Simple Absorption-type Split)
-
Mar. 30, 2022
Notice Regarding Transfer of Non-current Asset and Recognition of Other Income
-
Feb. 22, 2022
Notice Regarding the Status and Completion of Stock Repurchase
-
Feb. 04, 2022
Notification for the Candidate for the Board of Directors
-
Feb. 02, 2022
Notice Regarding the Status of Stock Repurchase
-
Jan. 24, 2022
Notice Concerning Judgement of the Lawsuit against Consolidated Subsidiary and Launch of Appeal
-
Jan. 05, 2022
Notice Regarding the Status of Stock Repurchase
